Urolithin A for Runners: Endurance & Recovery

Distance running is, more than almost any sport, a mitochondrial event. Your ability to hold pace late in a long run depends on the density and quality of the mitochondria in your legs. Urolithin A acts on exactly that machinery, and unlike most endurance supplements it now has a dedicated human runner trial behind it. Here is the honest evidence and how to use it across a training block.

Why running lives and dies on mitochondrial quality

Endurance is fundamentally an aerobic energy problem. When you run at a sustainable pace, your working muscles produce most of their ATP inside mitochondria using oxygen, and one of the central adaptations to endurance training is a rise in mitochondrial density and efficiency in the trained fibers. That is a big part of why a well-trained aerobic system can hold a pace that leaves an untrained runner gasping: more capable mitochondria mean more fuel burned aerobically and less reliance on the anaerobic pathways that fatigue you quickly.

But mitochondria wear out, especially under the repeated mechanical and metabolic stress of high mileage. Cells maintain quality through mitophagy, a recycling process that removes damaged mitochondria so healthier ones can replace them. When this housekeeping runs well, the muscle keeps a cleaner, more efficient mitochondrial pool. Urolithin A is a gut postbiotic your microbiome makes from ellagitannins in pomegranate, walnuts, and berries, and its signature property is that it supports mitophagy. Because only some people carry the gut bacteria that convert those food precursors efficiently, a standardized supplement is the dependable way to get a consistent dose. For the deeper mechanism, see mitochondrial health and what is mitophagy.

The runner-specific human evidence

Endurance supplements rarely have a study in the exact population that would buy them. Urolithin A is an exception, and it is worth separating the runner-specific data from the broader human and preclinical work.

The distance-runner trial

A 2025 trial in distance runners (indexed at PMC12628386) is the most directly relevant human study for this audience. It examined urolithin A in the context of running performance, recovery, and mitochondrial biomarkers in trained runners. This matters because it moves the compound out of general or older-adult populations and into the legs of people doing real endurance work. As with the rest of this field, it is a single trial of modest size, so the responsible way to describe it is that urolithin A supported the performance and recovery-related and mitochondrial measures examined in runners, not that it guarantees a faster race.

The broader human performance base

The runner trial sits on top of a solid base of general human evidence. Singh and colleagues (2022, Cell Reports Medicine) ran a four-month randomized study in middle-aged adults with 500 mg and 1,000 mg arms and reported improved muscle strength and exercise performance. Liu, D'Amico and colleagues (2022, JAMA Network Open) studied older adults over about four months and measured muscle endurance as contractions before fatigue, with favorable mitochondrial and cellular markers, a fatigue-resistance endpoint that resonates with any distance athlete. An 8-week randomized controlled trial in resistance-trained men (2024, Journal of the International Society of Sports Nutrition) added endurance and recovery-marker data in an already-trained cohort. Underpinning all of it, the first-in-human safety study by Andreux and colleagues (2019, Nature Metabolism) showed urolithin A is safe and well tolerated up to 1,000 mg per day and produces a mitochondrial gene-expression signature in humans.

The preclinical foundation, labeled as such

The mechanism was first established in animals and cells. Ryu and colleagues (2016, Nature Medicine) showed urolithin A stimulated mitophagy, improved muscle function in rodents, and extended lifespan in C. elegans. A 2025 Nature Aging randomized trial (about 28 days) is human but focused on immune-cell mitochondrial health in the setting of age-related inflammation, useful supportive context for the recovery side rather than a running-performance result. Keep the layers straight: the rodent and worm work explains the biology, the human trials test it, and only the human trials speak to what a runner can expect.

How to use it across a training block

Urolithin A is a daily supplement, not a race-day or pre-run trick. It supports an ongoing cellular recycling process, so its effect is built through consistency, not through timing around a workout. Take the full serving once a day, on easy days and long-run days alike. The clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top of that range and matching the arm used in the strength-and-performance work; the SOMA HEALTH serving delivers 1,000 mg in four gummies.

Because benefits in the trials emerged over weeks to months, the sensible way to evaluate it is across a full training cycle rather than a single week. A build phase into a goal race is a natural window: start early in the block and keep it consistent through the taper. It layers on top of, and never replaces, the real drivers of endurance improvement, which are structured mileage, adequate fueling and iron status, and sleep. For scheduling and timelines, see how to take urolithin A, urolithin A dosage, and how long urolithin A takes to work.

Honest limits and a health note

The 2024 systematic review in Ageing Research Reviews is the fair reference point: the human evidence is promising but still emerging, with short trials and modest sample sizes, including the runner study. Urolithin A supports normal muscle, endurance, and mitochondrial processes; it is not a treatment for any medical condition, and it will not compensate for under-fueling, low iron, poor sleep, or a training plan that is too aggressive. Runners are prone to specific medical issues, from stress-related bone and joint problems to iron deficiency, and those require a clinician, not a supplement. If you have unexplained fatigue, chest symptoms, or persistent pain, see your doctor rather than adjusting a supplement. For the complete picture, read our full urolithin A guide, our best urolithin A gummies roundup, and our urolithin A for energy page.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.